Workshop
Event Title
Public Workshop - Medical Extended Reality: Toward Best Evaluation Practices for Virtual and Augmented Reality in Medicine
March 5, 2020
- Date:
- March 5, 2020
- Time:
-
8:30 AM - 5:00 PM ET
- Location:
-
Event LocationWhite Oak Campus: The Great Room
Conference Center
10903 New Hampshire Ave
Building 31, Room 1503
Silver Spring, MD 20993
United States
INTRODUCTION
The Food and Drug Administration (FDA) is announcing the following public workshop entitled "Medical Extended Reality: Toward Best Evaluation Practices for Virtual and Augmented Reality in Medicine." The purpose of the public workshop is to discuss evaluation techniques for hardware, standards development, and assessment challenges for applications of Extended Reality (XR) in medicine. The goal is to identify critical gaps that may impede medical XR device development, innovation, and to advance the evaluation of medical XR devices and applications, thus accelerating the development of safe and effective medical XR devices benefiting patients and healthcare.
We are organizing a public workshop focused on discussing evaluation needs, gaps, and approaches for medical XR devices. The overarching vision of the workshop is to help advance the development of evaluation techniques for medical XR devices and applications to ultimately accelerate the development of safe and effective medical uses of XR, providing benefits to patients. Identifying evaluation technical needs and approaches as well as addressing critical gaps that impede device development is essential for innovation and use of XR in medical applications.
During the workshop, we will be discussing specific topics outlined in the Agenda below.
DATE, TIME and LOCATION
This meeting will be held on March 5, 2020, from 8:30 a.m. to 5:00 p.m. (EST) at the following location:
FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503 (the Great Room)
Silver Spring, MD, 20993
WEBCAST ARCHIVE
PRELIMINARY AGENDA
The following public workshop Agenda is preliminary and subject to change. More information will be made available as presenters are confirmed.
| Time | Event |
|---|---|
| 8:30 AM | Opening Remarks Edward Margerrison (Director, OSEL/CDRH/FDA) Welcome and event introduction. |
| Emerging Technology and Methods I Moderator: Aldo Badano (Deputy Director, DIDSR/OSEL/CDRH/FDA) This session will provide an overview of emerging augmented and virtual reality technology, current evaluation methods, and evaluation challenges. |
|
| 8:40 AM | Rafael Grossmann, MD, FACS Keynote address on extended reality devices in medicine. |
| 9:00 AM | Bernard Kress, Microsoft Advances in mixed reality devices and new evaluation challenges |
| 9:15 AM | Hiroshi Mukawa, Sony Emerging technologies for addressing performance limitations in extended reality devices, such as motion-to-photon latency compensation, and retinal scan displays. |
| 9:30 AM | Vinay Narayan, HTC Advances in virtual reality devices and characterization methods |
| 9:45 AM | Don Gyou Lee, LG Advances in display technology and evaluation challenges |
| 10:00 AM | Kevin MacKenzie, Facebook Reality Labs Next-generation extended reality devices and evaluation methods |
| 10:15 AM | Panel Discussion Discussion on topics from Emerging Technology and Methods I |
| 10:45 AM | Coffee Break |
| Emerging Technology and Methods II Moderator: Ryan Beams (DIDSR/OSEL/CDRH/FDA) This session is part 2 of the emerging augmented and virtual reality technology, current evaluation methods, and evaluation challenges with a greater emphasis on medicine. |
|
| 11:00 AM | Ryan Beams, DIDSR/OSEL/CDRH/FDA FDA research in characterizing extended reality devices |
| 11:05 AM | Hong Hua, University of Arizona Current research in extended reality devices and evaluation methods |
| 11:20 AM | Jennifer Esposito, Magic Leap Opportunities and challenges for extended reality devices in medicine |
| 11:35 AM | Nassir Navab, Johns Hopkins University Current research in medical applications of extended reality |
| 11:50 AM | John Penczek, NIST Progress in standards for extended reality devices |
| 12:00 PM | Panel Discussion Discussion on topics from Emerging Technology and Methods II |
| 12:30 PM | Lunch Brown bag poster session: Medical Extended-Reality Research at the FDA Andrea Kim, DIDSR/OSEL/CDRH/FDA |
| Medical Applications I Moderator: Kimberly Kontson (DBP/OSEL/CDRH/FDA) This session addresses current research into the application of extended reality devices and the challenges using these technologies. |
|
| 1:30 PM | Kimberly Kontson, DBP/OSEL/CDRH/FDA FDA research in human factors challenges for extended reality device |
| 1:35 PM | Atul Gupta, Philips Opportunities and challenges for extended reality devices in medicine |
| 1:50 PM | Christoph Leuze, Stanford University Current research in medical applications of extended reality |
| 2:00 PM | Amitabh Varshney, University of Maryland Current research in medical applications of extended reality |
| 2:10 PM | Brennan Spiegel, Cedars-Sinai Medical Center Clinical research on medical applications of extended reality |
| 2:20 PM | Dimitri Amiras, Imperial College Healthcare NHS Trust Clinical research in medical applications of extended reality |
| 2:30 PM | Panel Discussion Discussion on topics from Medical Applications I |
| 3:00 PM | Coffee Break |
| Medical Applications II Moderator: Kyoko Fujimoto (DBP/OSEL/CDRH/FDA) This session is part 2 of the medical applications with presentations from companies developing medical applications with an emphasis on the evaluation challenges. |
|
| 3:15 PM | Naoji Taniguchi, HoloEyes Medical image visualization and evaluation challenges using AR |
| 3:20 PM | Tassilo Baeuerle/Harald Stock, CognifiSense Treating pain in VR and the evaluation challenges |
| 3:25 PM | Christopher Morley, Medvis Medical image visualization and evaluation challenges using AR |
| 3:30 PM | Jennifer Silva, SentiAR Medical image visualization and evaluation challenges using AR |
| 3:35 PM | Joe Powers, appliedVR Treating pain in VR and associated evaluation challenges |
| 3:40 PM | Ben Lewis, Limbix Mental health therapy in VR and the evaluation challenges |
| 3:45 PM | Tran Tu Huynh, OpticSurg AR surgery and evaluation challenges |
| 3:50 PM | Walter Greenleaf, Stanford University Current research in medical extended reality devices |
| 3:55 PM | Panel Discussion Discussion on topics from Medical Applications II |
| 4:10 PM | Break |
| Wrap-up Session Moderator: Aldo Badano (DIDSR/OSEL/CDRH/FDA) This session will provide a final panel discussion on extended reality devices in medicine and closing remarks. |
|
| 4:15 PM | Wrap-up Panel Discussion Discussion on topics spanning the sessions covered in the workshop and follow up activities |
| 5:00 PM | Closing Remarks, Aldo Badano (DIDSR/OSEL/CDRH/FDA) |
REGISTRATION
Registration is now closed, but you can still use the webcast link to view the workshop.
COMMENTS
Please submit your comments regarding the workshop to https://www.regulations.gov/, Docket No. FDA 2020-N-0169 by April 10, 2020.
Please refer to the Instructions for submitting comments to the docket to ensure that your feedback is taken into consideration.
The workshop transcript will be posted in the Docket No. FDA-2020-N-0169 as soon as it is available and accessible at http://www.regulations.gov.
CONTACT
For questions regarding public workshop content please contact:
Aldo Badano
Center for Devices and Radiological Health
Food and Drug Administration
10903 New Hampshire Ave.
Bldg. 62, Rm. 3116
Silver Spring, MD 20993
301-796-2534
[email protected]
Event Materials
| Title | File Type/Size |
|---|---|
| Public Workshop - Medical Extended Reality: Toward Best Evaluation Practices for Virtual and Augmented Reality in Medicine | pdf (1.74 MB) |